Grant Application

REQUEST FOR PROPOSALS (RFP)

GLA is no longer accepting RFPs for its 2017-18 grants cycle (submission dates were June 15, 2017 to September 18, 2017). Proposals are being reviewed and funding decisions will be announced in December 2017.

GRANT REVIEW PROCESS

Grants are reviewed by the Grant Review Committee (GRC) of the Scientific Advisory Board (SAB), composed of experts in the tick-borne diseases research field. The Financial Review Committee (FRC) is available to advise in the event of any conflicts of interest or for commercial applications. Applications are reviewed by GLA to assure completion before review by the SAB.

REVIEWERS COMMENT ON SEVERAL ASPECTS OF THE APPLICATION

  • Significance or impact of the study to drive the science concerning Lyme and other tick-borne diseases forward
  • Expertise and previous rate of success of principal investigator and collaborators
  • Innovation supported by fact-based concepts and methods
  • Compatibility of the scope of work to the specific goals of the project/compatibility of the scope of work to the proposed budget
  • Appropriate scientific environment

Once the entire grant review process is completed, the committee meets to discuss and prioritize the grant application award list in conjunction with the monies available, as assigned by GLA’s Executive Committee. The GRC makes its recommendations to the GLA Board of Directors, who make final decisions following majority approval of these recommendations.

All grant recipients are required to sign a Research Grant Agreement, created to protect both the grant recipient(s) and GLA. These agreements are tailored to each individual grant and are subject to negotiation. Monies are only awarded to a medical institution, foundation, or university, never to an individual. GLA accepts up to 10% indirect costs.

Preload